Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer
暂无分享,去创建一个
[1] M. Ron,et al. The Secondary Schizophrenias , 2011 .
[2] Haym Benaroya. Science and commerce , 2010 .
[3] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[4] M. Gallucci,et al. Genetic profile identification in clinically localized prostate carcinoma. , 2009, Urologic oncology.
[5] J Miller,et al. A high-density SNP genome-wide linkage scan in a large autism extended pedigree , 2009, Molecular Psychiatry.
[6] J. Nurnberger,et al. Identifying blood biomarkers for mood disorders using convergent functional genomics , 2009, Molecular Psychiatry.
[7] Michael Wagner,et al. Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. , 2008, Journal of psychiatric research.
[8] A M McIntosh,et al. The effects of a neuregulin 1 variant on white matter density and integrity , 2008, Molecular Psychiatry.
[9] R. Ophoff,et al. An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia , 2008, Molecular Psychiatry.
[10] K. Huse,et al. High‐resolution mapping of the 8p23.1 beta‐defensin cluster reveals strictly concordant copy number variation of all genes , 2008, Human mutation.
[11] G. Kirov,et al. Support for Neuregulin 1 as a Susceptibility Gene for Bipolar Disorder and Schizophrenia , 2008, Biological Psychiatry.
[12] A. Preti. Reduced risk of cancer in schizophrenia: a role for obstetric complications? , 2008, Acta psychiatrica Scandinavica.
[13] C. DeLisi,et al. Identification of novel epigenetic markers for clear cell renal cell carcinoma. , 2008, The Journal of urology.
[14] M. Phillips,et al. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder , 2008, Molecular Psychiatry.
[15] I. Thesleff,et al. Identification of dkk4 as a target of Eda-A1/Edar pathway reveals an unexpected role of ectodysplasin as inhibitor of Wnt signalling in ectodermal placodes. , 2008, Developmental biology.
[16] O. Isacson,et al. Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. , 2008, Brain : a journal of neurology.
[17] I. Cobos,et al. FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development , 2008, Neural Development.
[18] J. Sutcliffe. Insights into the Pathogenesis of Autism , 2008, Science.
[19] J. Rubenstein,et al. Frontal cortex subdivision patterning is coordinately regulated by Fgf8, Fgf17, and Emx2 , 2008, The Journal of comparative neurology.
[20] A. Chase,et al. Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia , 2008, International journal of hematology.
[21] Anat Achiron,et al. Breast cancer in women suffering from serious mental illness , 2008, Schizophrenia Research.
[22] John P A Ioannidis,et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.
[23] D. Geschwind,et al. Heterogeneous dysregulation of microRNAs across the autism spectrum , 2008, neurogenetics.
[24] M. Toyota,et al. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma , 2008, Journal of Gastroenterology.
[25] Päivi Heikkilä,et al. NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer , 2008, Nature Genetics.
[26] Dai Zhang,et al. Two-stage designs to identify the effects of SNP combinations on complex diseases , 2008, Journal of Human Genetics.
[27] Claudia Petritsch,et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells , 2008 .
[28] S. Nomoto,et al. Quantitative promoter methylation analysis of hepatocellular carcinoma, cirrhotic and normal liver , 2008, International journal of cancer.
[29] H. Sekhon,et al. Activated cholinergic signaling provides a target in squamous cell lung carcinoma. , 2008, Cancer research.
[30] Jing-ping Zhao,et al. Explorative study on the expression of neuregulin-1 gene in peripheral blood of schizophrenia , 2008, Neuroscience Letters.
[31] B. Alger,et al. Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus , 2008, Proceedings of the National Academy of Sciences.
[32] A. Cesario,et al. The cholinergic system and cancer. , 2008, Seminars in cancer biology.
[33] B. Lerer,et al. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia , 2008, The Pharmacogenomics Journal.
[34] Paul Pavlidis,et al. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model , 2008, Nature Genetics.
[35] S. Gabriel,et al. Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.
[36] L. Mei,et al. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia , 2008, Nature Reviews Neuroscience.
[37] John D Potter,et al. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. , 2008, JAMA.
[38] C. Sumiyoshi,et al. Calcineurin A gamma and B gene expressions in the whole blood in Japanese patients with schizophrenia , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[39] J. Potash,et al. The genetics of psychotic bipolar disorder , 2008, Current psychiatry reports.
[40] W. Berrettini,et al. Association between Polymorphisms in the Vesicular Monoamine Transporter 1 Gene (VMAT1/SLC18A1) on Chromosome 8p and Schizophrenia , 2008, Neuropsychobiology.
[41] Aaron D. J. Frost,et al. Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis , 2008, Acta psychiatrica Scandinavica.
[42] I. Levav,et al. Enhanced cancer risk among patients with bipolar disorder. , 2008, Journal of affective disorders.
[43] M. Caligiuri,et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. , 2008, The New England journal of medicine.
[44] Joshua M. Korn,et al. Mapping and sequencing of structural variation from eight human genomes , 2008, Nature.
[45] J. Milbrandt,et al. Mice Lacking the Immediate Early Gene Egr3 Respond to the Anti-Aggressive Effects of Clozapine Yet are Relatively Resistant to its Sedating Effects , 2008, Neuropsychopharmacology.
[46] A. Regev,et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.
[47] Masatoshi Takeda,et al. TGFBR2 gene expression and genetic association with schizophrenia. , 2008, Journal of psychiatric research.
[48] A. Singleton,et al. Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia , 2008, Science.
[49] R. Moon,et al. Wnt5a Control of Cell Polarity and Directional Movement by Polarized Redistribution of Adhesion Receptors , 2008, Science.
[50] N. Craddock,et al. Cis- and trans- loci influence expression of the schizophrenia susceptibility gene DTNBP1. , 2008, Human molecular genetics.
[51] Izuho Hatada,et al. MeCP2-dependent repression of an imprinted miR-184 released by depolarization. , 2008, Human molecular genetics.
[52] Marlene Norrby,et al. Secreted frizzled related protein 1 (Sfrp1) and Wnt signaling in innervated and denervated skeletal muscle , 2008, Journal of Molecular Histology.
[53] G. Daley,et al. Selective Blockade of MicroRNA Processing by Lin28 , 2008, Science.
[54] Paolo Vineis,et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.
[55] L. Mucke,et al. Abnormal social behaviors in mice lacking Fgf17 , 2008, Genes, brain, and behavior.
[56] M. Butler,et al. Array comparative genomic hybridization (aCGH) analysis in Prader–Willi syndrome , 2008, American journal of medical genetics. Part A.
[57] Lin He,et al. No association found between the promoter variants of ADRA1A and schizophrenia in the Chinese population. , 2008, Journal of psychiatric research.
[58] D. Stokoe,et al. PTEN in brain tumors , 2008, Expert review of neurotherapeutics.
[59] Jianxin Shi,et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. , 2008, The American journal of psychiatry.
[60] S. Horvath,et al. Variations in DNA elucidate molecular networks that cause disease , 2008, Nature.
[61] J. Gallinat,et al. Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits , 2008, Neuroscience Letters.
[62] J. Rubenstein,et al. Compartment-specific transcription factors orchestrate angiogenesis gradients in the embryonic brain , 2008, Nature Neuroscience.
[63] A. Avogaro,et al. Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid? , 2008, Free radical biology & medicine.
[64] George A Calin,et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. , 2008, Blood.
[65] G. Prendergast,et al. Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging. , 2008, Cancer research.
[66] A. Serretti,et al. The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directions , 2008, Molecular Psychiatry.
[67] Vladimir I. Vladimirov,et al. AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families , 2008, Biological Psychiatry.
[68] Y. Shu,et al. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization. , 2008, Cancer genetics and cytogenetics.
[69] Y. Chagnon,et al. Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes , 2008, Schizophrenia Research.
[70] J. Serratosa,et al. Autosomal dominant nocturnal frontal lobe epilepsy with a mutation in the CHRNB2 gene , 2008, Epilepsia.
[71] J. Rahnenführer,et al. Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer. , 2008, Cancer genomics & proteomics.
[72] P. Dasgupta,et al. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. , 2008, Trends in pharmacological sciences.
[73] G. Mayhew,et al. Gene‐Gene Interaction Between FGF20 and MAOB in Parkinson Disease , 2008, Annals of human genetics.
[74] M. Webster,et al. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients , 2008, Schizophrenia Research.
[75] H. Liu,et al. NAT2*7 Allele Is a Potential Risk Factor for Adult Brain Tumors in Taiwanese Population , 2008, Cancer Epidemiology Biomarkers & Prevention.
[76] A. Joyner,et al. Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signaling during development , 2008, Development.
[77] Michael E Talkowski,et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. , 2008, Human molecular genetics.
[78] A. Serretti,et al. Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[79] Hanlin Gao,et al. A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD) , 2008, American journal of medical genetics. Part A.
[80] J. Waddington,et al. Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous ‘knockout’ of the schizophrenia risk gene neuregulin-1 , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[81] C. Morton,et al. Structural genomic variation and personalized medicine. , 2008, The New England journal of medicine.
[82] Gaofeng Wang,et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. , 2008, American journal of human genetics.
[83] D. Pinto,et al. Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.
[84] Nobumasa Kato,et al. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains , 2008, Neuroscience Research.
[85] C. Kaltschmidt,et al. Characterization of a neuregulin-1 gene promoter: positive regulation of type I isoforms by NF-kappaB. , 2008, Biochimica et biophysica acta.
[86] Kevin A. Pelphrey,et al. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders , 2008, Schizophrenia Research.
[87] R. Schwartz,et al. Molecular origins of cancer. , 2008, The New England journal of medicine.
[88] A. Üren,et al. Wnt-3a and Dickkopf-1 Stimulate Neurite Outgrowth in Ewing Tumor Cells via a Frizzled3- and c-Jun N-Terminal Kinase-Dependent Mechanism , 2008, Molecular and Cellular Biology.
[89] J. Couzin. Gene Tests for Psychiatric Risk Polarize Researchers , 2008, Science.
[90] M. Cairns,et al. Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. , 2008, Human molecular genetics.
[91] Marta Di Forti,et al. Positional Pathway Screen of wnt Signaling Genes in Schizophrenia: Association with DKK4 , 2008, Biological Psychiatry.
[92] P. Bouloux,et al. Diversity in Fibroblast Growth Factor Receptor 1 Regulation: Learning from the Investigation of Kallmann Syndrome , 2007, Journal of neuroendocrinology.
[93] M. Munafo,et al. Neuregulin 1 genotype and schizophrenia. , 2007, Schizophrenia bulletin.
[94] M. Fernando,et al. The α1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-κB signalling to induce breast cancer cell apoptosis , 2008 .
[95] I. V. Kostomarov,et al. [The relation between gene of lipoprotein-lipase and carrier protein of cholesterol ethers and life duration in patients with chronic cerebral ischemia]. , 2008, Klinicheskaia meditsina.
[96] M. Fernando,et al. The alpha1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-kappaB signalling to induce breast cancer cell apoptosis. , 2008, European journal of cancer.
[97] Mads Thomassen,et al. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis , 2008, Breast Cancer Research and Treatment.
[98] S. Purcell,et al. Family-based association study of lithium-related and other candidate genes in bipolar disorder. , 2008, Archives of general psychiatry.
[99] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[100] Jean-Yves Delattre,et al. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile , 2008, Molecular Cancer.
[101] R. Holcombe,et al. Wnt Pathway-Related Gene Expression in Inflammatory Bowel Disease , 2008, Digestive Diseases and Sciences.
[102] M. Leboyer,et al. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and bipolar disorder , 2008, Behavioral and Brain Functions.
[103] D. Weinberger,et al. Neuregulin-1 Regulates Cell Adhesion via an ErbB2/Phosphoinositide-3 Kinase/Akt-Dependent Pathway: Potential Implications for Schizophrenia and Cancer , 2007, PloS one.
[104] E. Pennisi,et al. Human Genetic Variation , 2007, Science.
[105] Matthew D. Lieberman,et al. Social cognitive neuroscience: a review of core processes. , 2007, Annual review of psychology.
[106] M. Shen,et al. FGF signaling in prostate tumorigenesis--new insights into epithelial-stromal interactions. , 2007, Cancer cell.
[107] B. Eickholt,et al. Function of PTEN during the Formation and Maintenance of Neuronal Circuits in the Brain , 2007, Developmental Neuroscience.
[108] Kohzoh Imai,et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. , 2007, Carcinogenesis.
[109] David Stokoe,et al. New insights into PTEN , 2007, Journal of Cell Science.
[110] Satoko Kato,et al. Calpain‐mediated cleavage of collapsin response mediator protein(CRMP)‐2 during neurite degeneration in mice , 2007, The European journal of neuroscience.
[111] A. Chase,et al. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. , 2007, Blood.
[112] L. Bennetto,et al. Olfaction and Taste Processing in Autism , 2007, Biological Psychiatry.
[113] Philip M. Kim,et al. Paired-End Mapping Reveals Extensive Structural Variation in the Human Genome , 2007, Science.
[114] Xiaohang Zhao,et al. Identification of Candidate Biomarkers for Hepatocellular Carcinoma Through Pre-Cancerous Expression Analysis in an HBx Transgenic Mouse , 2007, Cancer biology & therapy.
[115] M. Koga,et al. Support for association of the PPP3CC gene with schizophrenia , 2007, Molecular Psychiatry.
[116] N. Itoh. The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. , 2007, Biological & pharmaceutical bulletin.
[117] Xavier Estivill,et al. Disorders: Filling the Gaps and Exploring Complexity in Genome-Wide Association Studies , 2022 .
[118] Tsung-Cheng Chang,et al. microRNAs in vertebrate physiology and human disease. , 2007, Annual review of genomics and human genetics.
[119] Xin Duan,et al. Disrupted-In-Schizophrenia 1 Regulates Integration of Newly Generated Neurons in the Adult Brain , 2007, Cell.
[120] Ole A. Andreassen,et al. Brain Expressed microRNAs Implicated in Schizophrenia Etiology , 2007, PloS one.
[121] M. P. Howell,et al. The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty , 2007, Neuroscience.
[122] S. Christian,et al. No evidence for association between 19 cholinergic genes and bipolar disorder , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[123] K. Honczarenko,et al. The role of NAT2 gene polymorphism in aetiology of the most frequent neurodegenerative diseases with dementia. , 2007, Neurologia i neurochirurgia polska.
[124] Chi-Ying F. Huang,et al. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits. , 2007, Lung cancer.
[125] C. Robson,et al. Selective over‐expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer , 2007, The Journal of pathology.
[126] S. Hyman. Can neuroscience be integrated into the DSM-V? , 2007, Nature Reviews Neuroscience.
[127] Paul J. Harrison,et al. Molecular Cloning of a Brain-specific, Developmentally Regulated Neuregulin 1 (NRG1) Isoform and Identification of a Functional Promoter Variant Associated with Schizophrenia*♦ , 2007, Journal of Biological Chemistry.
[128] H. Hano,et al. Identification of minimal regions of deletion at 8p23.1‐22 associated with metastasis of hepatocellular carcinoma , 2007, Liver international : official journal of the International Association for the Study of the Liver.
[129] Y. Meng,et al. Association studies between the plasmin genes and late-onset Alzheimer's disease , 2007, Neurobiology of Aging.
[130] Jonathan Sebat,et al. Major changes in our DNA lead to major changes in our thinking , 2007, Nature Genetics.
[131] Alfons Meindl,et al. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. , 2007, Carcinogenesis.
[132] P. Mortensen,et al. Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. , 2007, The Journal of clinical psychiatry.
[133] Alexander Eckehart Urban,et al. in the human genome Systematic prediction and validation of breakpoints associated with copy-number variants , 2007 .
[134] Nobutaka Hattori,et al. Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population , 2007, Neuroreport.
[135] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.
[136] M. Katoh. Networking of WNT, FGF, Notch, BMP, and Hedgehog Signaling Pathways during Carcinogenesis , 2007, Stem Cell Reviews.
[137] D. Amaral,et al. Autoantibodies in Autism Spectrum Disorders (ASD) , 2007, Annals of the New York Academy of Sciences.
[138] Takashi Suzuki,et al. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. , 2007, Endocrine-related cancer.
[139] D. Lancet,et al. Association of the dopamine receptor interacting protein gene, NEF3, with early response to antipsychotic medication. , 2007, The international journal of neuropsychopharmacology.
[140] L. A. McInnes,et al. The NRG1 exon 11 missense variant is not associated with autism in the Central Valley of Costa Rica , 2007, BMC psychiatry.
[141] Luc Girard,et al. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. , 2007, Cancer research.
[142] H. Miyaoka,et al. Decreased lipoprotein lipase as a risk factor for atypical neuroleptic-induced hypertriglyceridemia. , 2007, The Journal of clinical psychiatry.
[143] Paul J. Harrison. Schizophrenia Susceptibility Genes and Neurodevelopment , 2007, Biological Psychiatry.
[144] John G. Sled,et al. Behavioral Phenotypes of Disc1 Missense Mutations in Mice , 2007, Neuron.
[145] K. Becker,et al. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: Relevance to oxidative damage in Parkinson's disease , 2007, Neurochemistry International.
[146] G. Opala,et al. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease. , 2007, Parkinsonism & related disorders.
[147] J. Highton,et al. Rationale for a trial of immunosuppressive therapy in acute schizophrenia , 2007, Molecular Psychiatry.
[148] J. Rubenstein,et al. Patterning of frontal cortex subdivisions by Fgf17 , 2007, Proceedings of the National Academy of Sciences.
[149] M. Kas,et al. Genetics of behavioural domains across the neuropsychiatric spectrum; of mice and men , 2007, Molecular Psychiatry.
[150] J. Enghild,et al. Proteomic Investigation of the Ventral Rat Hippocampus Links DRP-2 to Escitalopram Treatment Resistance and SNAP to Stress Resilience in the Chronic Mild Stress Model of Depression , 2007, Journal of Molecular Neuroscience.
[151] M. Nelson,et al. Profiling of selenomethionine responsive genes in colon cancer by microarray analysis , 2007, Cancer biology & therapy.
[152] R. Schultz,et al. Autistic-like symptomatology in Prader-Willi syndrome: A review of recent findings , 2007, Current psychiatry reports.
[153] C. Grothe,et al. The physiological and pharmacological role of basic fibroblast growth factor in the dopaminergic nigrostriatal system , 2007, Brain Research Reviews.
[154] R. Adolphs,et al. Agenesis of the corpus callosum: genetic, developmental and functional aspects of connectivity , 2007, Nature Reviews Neuroscience.
[155] Michael J. Birrer,et al. Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling , 2007, Oncogene.
[156] M. Kastan. Wild-Type p53: Tumors Can't Stand It , 2007, Cell.
[157] S. Faraone,et al. More evidence supports the association of PPP3CC with schizophrenia , 2007, Molecular Psychiatry.
[158] Susumu Tonegawa,et al. Genetic analysis of the calcineurin pathway identifies members of the EGR gene family, specifically EGR3, as potential susceptibility candidates in schizophrenia , 2007, Proceedings of the National Academy of Sciences.
[159] M. Fraga,et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. , 2007, Cancer research.
[160] M. de Castro,et al. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism , 2007, Clinical endocrinology.
[161] No association between PPP3CC and schizophrenia in the Chinese population , 2007, Schizophrenia Research.
[162] Y. Liou,et al. Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia , 2007, Schizophrenia Research.
[163] J. Steele,et al. Genetics of recurrent early-onset major depression (GenRED): final genome scan report. , 2007, The American journal of psychiatry.
[164] I. Levav,et al. Cancer risk among parents and siblings of patients with schizophrenia , 2007, British Journal of Psychiatry.
[165] P Shaw,et al. Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories , 2007, Molecular Psychiatry.
[166] Peter Falkai,et al. Immunohistochemical Evidence for Impaired Neuregulin‐1 Signaling in the Prefrontal Cortex in Schizophrenia and in Unipolar Depression , 2007, Annals of the New York Academy of Sciences.
[167] S. Britsch. Introduction: Molecular control of development , 2007 .
[168] E. Pennisi. Breakthrough of the year. Human genetic variation. , 2007, Science.
[169] Winnie S. Liang,et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. , 2007, Neuron.
[170] J. Rubenstein,et al. Genetic regulation of prefrontal cortex development and function. , 2007, Novartis Foundation symposium.
[171] D. Butterfield,et al. Proteomics analysis of the Alzheimer's disease hippocampal proteome. , 2007, Journal of Alzheimer's disease : JAD.
[172] No association between a functional NAD(P)H , 2007, NeuroMolecular Medicine.
[173] D. Blackwood,et al. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population , 2007, Molecular Psychiatry.
[174] Stefan Britsch,et al. The neuregulin-I/ErbB signaling system in development and disease. , 2007, Advances in anatomy, embryology, and cell biology.
[175] K. Lesch,et al. FZD3 is not a risk gene for schizophrenia: a case-control study in a Caucasian sample. , 2007, Journal of neural transmission. Supplementum.
[176] Joel S Parker,et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder , 2007, Genome Biology.
[177] R. Canitano. Epilepsy in autism spectrum disorders , 2007, European Child & Adolescent Psychiatry.
[178] R. Tabarés-Seisdedos,et al. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: A preliminary study , 2006, Neuroscience.
[179] M. Brüne,et al. Theory of mind—evolution, ontogeny, brain mechanisms and psychopathology , 2006, Neuroscience & Biobehavioral Reviews.
[180] E. Torrey,et al. Prostate cancer and schizophrenia. , 2006, Urology.
[181] J. Biswas,et al. Expressions of Rac1, Tiam1 and Cdc42 in retinoblastoma. , 2006, Experimental eye research.
[182] Lin He,et al. An investigation of the dihydropyrimidinase-like 2 (DPYSL2) gene in schizophrenia: genetic association study and expression analysis. , 2006, The international journal of neuropsychopharmacology.
[183] Heather C Whalley,et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms , 2006, Nature Neuroscience.
[184] K. Arima,et al. Behavioral and Brain Functions Association Study of the Vesicular Monoamine Transporter 1 (vmat1) Gene with Schizophrenia in a Japanese Population , 2022 .
[185] G. Dawson,et al. Evidence for multiple loci from a genome scan of autism kindreds , 2006, Molecular Psychiatry.
[186] Paola Bovolenta,et al. Frizzled/RYK mediated signalling in axon guidance , 2006, Development.
[187] Sonja W. Scholz,et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.
[188] Y. Shoenfeld,et al. To smell the immune system: olfaction, autoimmunity and brain involvement. , 2006, Autoimmunity reviews.
[189] J. LaSalle,et al. Reduced MeCP2 Expression is Frequent in Autism Frontal Cortex and Correlates with Aberrant MECP2 Promoter Methylation , 2006, Epigenetics.
[190] J. Millonig,et al. En2 knockout mice display neurobehavioral and neurochemical alterations relevant to autism spectrum disorder , 2006, Brain Research.
[191] A. Brooks-Kayal,et al. Brain-derived Neurotrophic Factor (BDNF)-induced Synthesis of Early Growth Response Factor 3 (Egr3) Controls the Levels of Type A GABA Receptorα4 Subunits in Hippocampal Neurons* , 2006, Journal of Biological Chemistry.
[192] R. McKay,et al. A Specific Survival Response in Dopamine Neurons at Most Risk in Parkinson's Disease , 2006, The Journal of Neuroscience.
[193] C Caldas,et al. High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation , 2006, Oncogene.
[194] S. Spence,et al. Stratification based on language‐related endophenotypes in autism: Attempt to replicate reported linkage , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[195] Bernhard Radlwimmer,et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. , 2006, American journal of human genetics.
[196] C. Carney,et al. Medical Comorbidity in Women and Men With Bipolar Disorders: A Population-Based Controlled Study , 2006, Psychosomatic medicine.
[197] R. Houlston,et al. Meta-analysis and pooled re-analysis of copy number changes in colorectal cancer detected by comparative genomic hybridization. , 2006, Anticancer research.
[198] M. Walton,et al. A Role for the Macaque Anterior Cingulate Gyrus in Social Valuation , 2006, Science.
[199] J. Poirier,et al. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology , 2006, The European journal of neuroscience.
[200] Jürgen Gallinat,et al. Variations in the Vesicular Monoamine Transporter 1 Gene (VMAT1/SLC18A1) are Associated with Bipolar I Disorder , 2006, Neuropsychopharmacology.
[201] M. Webster,et al. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes , 2006, Molecular Psychiatry.
[202] D. Hochstrasser,et al. Changes of the cortex proteome and Apolipoprotein E in transgenic mouse models of Alzheimer's Disease. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[203] L. Almasy,et al. Linkage disequilibrium analyses in the Costa Rican population suggests discrete gene loci for schizophrenia at 8p23.1 and 8q13.3 , 2006, Psychiatric genetics.
[204] M. Iyo,et al. Association Study of the Dihydropyrimidinase‐Related Protein 2 Gene and Methamphetamine Psychosis , 2006, Annals of the New York Academy of Sciences.
[205] Steve Morgan,et al. The Common Drug Review: a NICE start for Canada? , 2006, Health policy.
[206] S. Roche,et al. First family-based test for association of neuregulin with bipolar affective disorder , 2006, Molecular Psychiatry.
[207] David Curtis,et al. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. , 2006, Archives of general psychiatry.
[208] P. Sedgwick,et al. Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder , 2006, Brain Research Bulletin.
[209] Paul J. Harrison,et al. Neuregulin 1 and Schizophrenia: Genetics, Gene Expression, and Neurobiology , 2006, Biological Psychiatry.
[210] J. Bobes,et al. N-acetyltransferase-2 polymorphisms and schizophrenia , 2006, European Psychiatry.
[211] Karin E. Borgmann-Winter,et al. Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.
[212] J. Todd. Statistical false positive or true disease pathway? , 2006, Nature Genetics.
[213] S. Ying,et al. First in vivo evidence of microRNA-induced fragile X mental retardation syndrome , 2006, Molecular Psychiatry.
[214] Y. Ahn,et al. Investigation of genetic association between human Frizzled homolog 3 gene (FZD3) and schizophrenia: Results in a Korean population and evidence from meta-analysis , 2006, Psychiatry Research.
[215] S. Hyman,et al. Can Autism Speak to Neuroscience? , 2006, The Journal of Neuroscience.
[216] A. Jablensky,et al. Subtyping schizophrenia: implications for genetic research , 2006, Molecular Psychiatry.
[217] Lin He,et al. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. , 2006, Human molecular genetics.
[218] Tushar Patel,et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. , 2006, Gastroenterology.
[219] R. Hard,et al. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic mice , 2006, Journal of Neurochemistry.
[220] Kyla Pennington,et al. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes , 2006, Proteomics.
[221] M. Munafo,et al. Association of the NRG1 gene and schizophrenia: a meta-analysis , 2006, Molecular Psychiatry.
[222] Paul J. Harrison,et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[223] D. Servent,et al. Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system. , 2006, Current medicinal chemistry.
[224] K. Papanikolaou,et al. A Case of Partial Trisomy of Chromosome 8p Associated with Autism , 2006, Journal of autism and developmental disorders.
[225] O. Marín,et al. Tangential Neuronal Migration Controls Axon Guidance: A Role for Neuregulin-1 in Thalamocortical Axon Navigation , 2006, Cell.
[226] B. Dean,et al. Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controls , 2006, Schizophrenia Research.
[227] W. Liu,et al. Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population , 2006, Acta psychiatrica Scandinavica.
[228] K. Ess. The neurobiology of tuberous sclerosis complex. , 2006, Seminars in pediatric neurology.
[229] T. Gilliam,et al. Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder , 2006, Molecular Psychiatry.
[230] Tak W. Mak,et al. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis , 2006, Nature Reviews Cancer.
[231] R. Jaenisch,et al. Postnatal Loss of Methyl-CpG Binding Protein 2 in the Forebrain is Sufficient to Mediate Behavioral Aspects of Rett Syndrome in Mice , 2006, Biological Psychiatry.
[232] E. Grove,et al. Area and layer patterning in the developing cerebral cortex , 2006, Current Opinion in Neurobiology.
[233] Pablo V Gejman,et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. , 2006, American journal of human genetics.
[234] Susumu Mori,et al. Axonal Growth and Guidance Defects in Frizzled3 Knock-Out Mice: A Comparison of Diffusion Tensor Magnetic Resonance Imaging, Neurofilament Staining, and Genetically Directed Cell Labeling , 2006, The Journal of Neuroscience.
[235] F. Tyson,et al. Environmental Epigenomics, Imprinting and Disease Susceptibility , 2006, Epigenetics.
[236] T. Insel,et al. Cure therapeutics and strategic prevention: raising the bar for mental health research , 2006, Molecular Psychiatry.
[237] J. Borlak,et al. N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease , 2006, BMC Medical Genetics.
[238] Eric Fombonne,et al. Epidemiology of autistic disorder and other pervasive developmental disorders. , 2005, The Journal of clinical psychiatry.
[239] Cheryl Corcoran,et al. Olfactory deficits, cognition and negative symptoms in early onset psychosis , 2005, Schizophrenia Research.
[240] Paul J. Harrison,et al. Differential expression of calcineurin A subunit mRNA isoforms during rat hippocampal and cerebellar development , 2005, The European journal of neuroscience.
[241] R. Huganir,et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. , 2005, American journal of human genetics.
[242] E. I. Rogaev,et al. Small RNAs in Human Brain Development and Disorders , 2005, Biochemistry (Moscow).
[243] C. Pato,et al. Human p53 tumor suppressor gene (TP53) and schizophrenia: Case–control and family studies , 2005, Neuroscience Letters.
[244] T. Nielsen,et al. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis , 2005, Oncogene.
[245] John M Greally,et al. Genetic mapping of putative Chrna7 and Luzp2 neuronal transcriptional enhancers due to impact of a transgene-insertion and 6.8 Mb deletion in a mouse model of Prader-Willi and Angelman syndromes , 2005, BMC Genomics.
[246] D. Pinkel,et al. Genomic microarray analysis identifies candidate loci in patients with corpus callosum anomalies , 2005, Neurology.
[247] B. Devlin,et al. Neuregulin‐1 polymorphism in late onset Alzheimer's disease families with psychoses , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[248] M. Sur,et al. Patterning and Plasticity of the Cerebral Cortex , 2005, Science.
[249] Mike Bly,et al. Mutation in the vesicular monoamine gene, SLC18A1, associated with schizophrenia , 2005, Schizophrenia Research.
[250] Jacques Corbeil,et al. Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[251] R Freedman,et al. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. , 2005, Brain research. Molecular brain research.
[252] U. Muthane,et al. Association of N-acetyl transferase 2 gene polymorphism and slow acetylator phenotype with young onset and late onset Parkinson's disease among Indians , 2005, Pharmacogenetics and genomics.
[253] Peter A. Jones,et al. Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer , 2005, Nature Clinical Practice Urology.
[254] R. Kerwin,et al. Polymorphisms in the Promoter Region of the Alpha1A-Adrenoceptor Gene Are Associated with Schizophrenia/Schizoaffective Disorder in a Spanish Isolate Population , 2005, Biological Psychiatry.
[255] R. Kessler,et al. The economic burden of schizophrenia in the United States in 2002. , 2005, The Journal of clinical psychiatry.
[256] C. Roehrborn,et al. A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia. , 2005, European urology.
[257] M J Owen,et al. Schizophrenia: genes at last? , 2005, Trends in genetics : TIG.
[258] Y. Liou,et al. Association analysis of NAD(P)Hratioquinone oxidoreductase (NQO1) Pro187Ser genetic polymorphism and tardive dyskinesia in patients with schizophrenia in Taiwan. , 2005, The international journal of neuropsychopharmacology.
[259] Hongkai Ji,et al. Why do human diversity levels vary at a megabase scale? , 2005, Genome research.
[260] A. Brooks-Kayal,et al. Egr3 stimulation of GABRA4 promoter activity as a mechanism for seizure-induced up-regulation of GABA(A) receptor alpha4 subunit expression. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[261] M. Momoi,et al. Mutation analysis of methyl-CpG binding protein family genes in autistic patients , 2005, Brain and Development.
[262] Andreas Papassotiropoulos,et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. , 2005, The Journal of clinical psychiatry.
[263] R. Buchanan,et al. Dihydropyrimidinase‐related protein 2 (DRP‐2) gene and association to deficit and nondeficit schizophrenia , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[264] H. Yao,et al. The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia , 2005, Molecular Psychiatry.
[265] W. Berrettini,et al. No association between common variations in the neuronal nicotinic acetylcholine receptor alpha2 subunit gene (CHRNA2) and bipolar I disorder , 2005, Psychiatry Research.
[266] A. Singleton,et al. Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients , 2005, BMC neurology.
[267] P. Mortensen,et al. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study , 2005, BMJ : British Medical Journal.
[268] G. Kirov,et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. , 2005, Archives of general psychiatry.
[269] J. Haines,et al. An autosomal genomic screen for dementia in an extended Amish family , 2005, Neuroscience Letters.
[270] F. Fumagalli,et al. Emerging role of the FGF system in psychiatric disorders. , 2005, Trends in pharmacological sciences.
[271] Y. Chagnon,et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families , 2005, Molecular Psychiatry.
[272] Paul J. Harrison,et al. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia , 2005, Biological Psychiatry.
[273] C. Dickson,et al. Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.
[274] D. Ambrosetti,et al. Mechanisms underlying differential responses to FGF signaling. , 2005, Cytokine & growth factor reviews.
[275] D. Storm,et al. The role of calmodulin as a signal integrator for synaptic plasticity , 2005, Nature Reviews Neuroscience.
[276] I. Levav,et al. Cancer in schizophrenia: is the risk higher or lower? , 2005, Schizophrenia Research.
[277] C. Aston,et al. Original Research Article , 2004 .
[278] L. Zwaigenbaum,et al. A Girl with Pervasive Developmental Disorder and Complex Chromosome Rearrangement Involving 8p and 10p , 2005, Journal of autism and developmental disorders.
[279] J. Bodfish,et al. The early development of stereotypy and self-injury: a review of research methods. , 2005, Journal of intellectual disability research : JIDR.
[280] K. Kaibuchi,et al. GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity , 2005, Cell.
[281] Christian Dina,et al. Fine mapping of a region on chromosome 8p gives evidence for a QTL contributing to individual differences in an anxiety‐related personality trait: TPQ harm avoidance , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[282] N. Cairns,et al. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[283] 吉村 武. GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity , 2005 .
[284] D. Perkins,et al. Expanding the ‘central dogma’: the regulatory role of nonprotein coding genes and implications for the genetic liability to schizophrenia , 2005, Molecular Psychiatry.
[285] S. Purcell,et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology , 2005, Molecular Psychiatry.
[286] T. Suzuki,et al. No association with the calcineurin A gamma subunit gene (PPP3CC) haplotype to Japanese schizophrenia , 2005, Journal of Neural Transmission.
[287] T. Suzuki,et al. Association study of the frizzled-3 (FZD3) gene with schizophrenia and mood disorders , 2005, Journal of Neural Transmission.
[288] C. Robson,et al. Fibroblast growth factor 17 is over‐expressed in human prostate cancer , 2004, The Journal of pathology.
[289] C. Papageorgiou,et al. Kallmann's Syndrome and Schizophrenia , 2004, International journal of psychiatry in medicine.
[290] Soo-Jung Lee,et al. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia. , 2004, The international journal of neuropsychopharmacology.
[291] T. Gilliam,et al. Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia , 2004, Molecular Psychiatry.
[292] P. Visscher,et al. A genome scan and follow-up study identify a bipolar disorder susceptibility locus on chromosome 1q42 , 2004, Molecular Psychiatry.
[293] M. Tsao,et al. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers , 2004, Oncogene.
[294] D. Louis,et al. Loss of p53 sensitizes mice with a mutation in Ccm1 (KRIT1) to development of cerebral vascular malformations. , 2004, The American journal of pathology.
[295] E G Jones,et al. Dysregulation of the fibroblast growth factor system in major depression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[296] G. He,et al. Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population , 2004, Neuroscience Letters.
[297] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[298] Carlos Caldas,et al. A Recurrent Chromosome Breakpoint in Breast Cancer at the NRG1/Neuregulin 1/Heregulin Gene , 2004, Cancer Research.
[299] T. Asada,et al. Genetic and expression analyses of FZD3 in schizophrenia , 2004, Biological Psychiatry.
[300] G. Moretto,et al. The H+ allele of the lipoprotein lipase (LPL) HindIII intronic polymorphism and the risk for sporadic late-onset Alzheimer’s disease , 2004, Neuroscience Letters.
[301] Q. Ma,et al. N-Acetyltransferase 2 gene polymorphism in a group of senile dementia patients in Shanghai suburb. , 2004, Acta pharmacologica Sinica.
[302] Jun Wei,et al. Lack of a genetic association between the frizzled-3 gene and schizophrenia in a British population , 2004, Neuroscience Letters.
[303] B. Maher,et al. Genome‐wide linkage survey for genetic loci that affect the risk of suicide attempts in families with recurrent, early‐onset, major depression , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[304] Xin Yu,et al. Positive association of the human frizzled 3 (FZD3) gene haplotype with schizophrenia in Chinese Han population , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[305] Kenny Q. Ye,et al. Large-Scale Copy Number Polymorphism in the Human Genome , 2004, Science.
[306] N. Craddock,et al. MECP2 structural and 3′‐UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[307] L. Fañanás,et al. Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits , 2004, Neuroscience Letters.
[308] Eden R Martin,et al. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. , 2004, American journal of human genetics.
[309] Ming T. Tsuang,et al. A Novel Permutation Testing Method Implicates Sixteen Nicotinic Acetylcholine Receptor Genes as Risk Factors for Smoking in Schizophrenia Families , 2004, Human Heredity.
[310] J. Buxbaum,et al. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia , 2004, Nature Neuroscience.
[311] C. Francks,et al. Genome-wide scan of reading ability in affected sibling pairs with attention-deficit/hyperactivity disorder: unique and shared genetic effects , 2004, Molecular Psychiatry.
[312] Eva Forssell-Aronsson,et al. Importance of Vesicle Proteins in the Diagnosis and Treatment of Neuroendocrine Tumors , 2004, Annals of the New York Academy of Sciences.
[313] E K Perry,et al. Autism as a disorder of neural information processing: directions for research and targets for therapy* , 2004, Molecular Psychiatry.
[314] W. Gerald,et al. Gene expression profiling predicts clinical outcome of prostate cancer. , 2004, The Journal of clinical investigation.
[315] R. Petersen,et al. An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease , 2004, Neuroscience Letters.
[316] JaneR . Taylor,et al. Loss of Glutamatergic Pyramidal Neurons in Frontal and Temporal Cortex Resulting from Attenuation of Fgfr1 Signaling Is Associated with Spontaneous Hyperactivity in Mice , 2022 .
[317] J. W. Kim,et al. Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients , 2004, Schizophrenia Research.
[318] R Hashimoto,et al. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.
[319] Sheng-tian Li,et al. Critical Role of Calpain-mediated Cleavage of Calcineurin in Excitotoxic Neurodegeneration* , 2004, Journal of Biological Chemistry.
[320] I. Dunham,et al. DNA sequence and analysis of human chromosome 9 , 2003, Nature.
[321] D. Malaspina,et al. Olfactory identification and WAIS-R performance in deficit and nondeficit schizophrenia , 2003, Schizophrenia Research.
[322] H. Simmonds,et al. Dihydropyrimidinase deficiency presenting in infancy with severe developmental delay , 1993, Journal of Inherited Metabolic Disease.
[323] Jack A. Taylor,et al. N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus. , 2004, The Journal of rheumatology.
[324] C. Gundersen,et al. Convergent Effects of Lithium and Valproate on the Expression of Proteins Associated with Large Dense Core Vesicles in NGF-differentiated PC12 Cells , 2004, Neuropsychopharmacology.
[325] A. Llerena,et al. Acetylator polymorphism in Parkinson's disease , 2004, European Journal of Clinical Pharmacology.
[326] M. Budge,et al. NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant , 2004, BMC Medical Genetics.
[327] H. Ujike,et al. The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia , 2003, Neuroscience Letters.
[328] Hongyan Zhang,et al. Association study of the human FZD3 locus with schizophrenia , 2003, Biological Psychiatry.
[329] B. Maher,et al. Genome‐wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early‐onset, major depression , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[330] H. Ujike,et al. No association between the dihydropyrimidinase-related protein 2 (DRP-2) gene and bipolar disorder in humans , 2003, Neuroscience Letters.
[331] D. Huylebroeck,et al. Slowed conduction and thin myelination of peripheral nerves associated with mutant rho Guanine-nucleotide exchange factor 10. , 2003, American journal of human genetics.
[332] H. Groenewegen,et al. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics , 2003, Neuroscience & Biobehavioral Reviews.
[333] D. Birnbaum,et al. Chromosome arm 8p and cancer: a fragile hypothesis. , 2003, The Lancet. Oncology.
[334] P. Goldman-Rakic,et al. Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling. , 2003, Trends in pharmacological sciences.
[335] D. Comas,et al. Association study between Alzheimer’s disease and genes involved in Aβ biosynthesis, aggregation and degradation: suggestive results with BACE1 , 2003, Journal of Neurology.
[336] E. Fombonne. Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update , 2003, Journal of autism and developmental disorders.
[337] Hongkui Zeng,et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[338] Susumu Tonegawa,et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[339] P. Visscher,et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. , 2003, American journal of human genetics.
[340] Francis J McMahon,et al. Genomewide linkage analyses of bipolar disorder: a new sample of 250 pedigrees from the National Institute of Mental Health Genetics Initiative. , 2003, American journal of human genetics.
[341] Leena Peltonen,et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.
[342] J B Eells. The control of dopamine neuron development, function and survival: insights from transgenic mice and the relevance to human disease. , 2003, Current medicinal chemistry.
[343] J. Haines,et al. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson’s disease , 2003, Neurology.
[344] H. Ujike,et al. The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia , 2003, Biological Psychiatry.
[345] Janice M. Fullerton,et al. Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. , 2003, American journal of human genetics.
[346] D. Blackwood,et al. Chromosomal abnormalities and mental illness , 2003, Molecular Psychiatry.
[347] W. T. Hung,et al. Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese , 2003, Neurology.
[348] R. Ebstein,et al. Tridimensional personality questionnaire trait of harm avoidance (anxiety proneness) is linked to a locus on chromosome 8p21 , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[349] R. Lupu,et al. Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer , 2003, Oncogene.
[350] E. Lander,et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.
[351] J. Couzin. Small RNAs Make Big Splash , 2002, Science.
[352] F. Wright,et al. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[353] Jeremy Nathans,et al. Frizzled-3 Is Required for the Development of Major Fiber Tracts in the Rostral CNS , 2002, The Journal of Neuroscience.
[354] Nelson B Freimer,et al. Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. , 2002, American journal of human genetics.
[355] G. Rebeck,et al. Lack of association of two lipoprotein lipase polymorphisms with Alzheimer's disease , 2002, Neuroscience Letters.
[356] C. Verney,et al. Changing distribution of monoaminergic markers in the developing human cerebral cortex with special emphasis on the serotonin transporter , 2002, The Anatomical record.
[357] R. Petersen,et al. No association between the lipoprotein lipase S447X polymorphism and Alzheimer's disease , 2002, Neuroscience Letters.
[358] A. Meyer-Lindenberg,et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia , 2002, Nature Neuroscience.
[359] J. Lotem,et al. NQO1 stabilizes p53 through a distinct pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[360] D. Sidransky,et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. , 2002, Cancer research.
[361] Emil Kraepelin,et al. Dementia praecox and paraphrenia , 2002 .
[362] R. Straub,et al. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes , 2002, Molecular Psychiatry.
[363] J. McGrath,et al. Genetic heterogeneity in schizophrenia II: conditional analyses of affected schizophrenia sibling pairs provide evidence for an interaction between markers on chromosome 8p and 14q , 2002, Molecular Psychiatry.
[364] E. Gershon,et al. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia , 2002, Molecular Psychiatry.
[365] K. Honczarenko,et al. N-acetyltransferase 2 polymorphism in sporadic Parkinson's disease in a Polish population , 2002, European Journal of Clinical Pharmacology.
[366] S. Tsai,et al. Association study of the p53-gene Pro72Arg polymorphism in schizophrenia , 2001, Psychiatry Research.
[367] M P Baur,et al. A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q. , 2001, Human molecular genetics.
[368] Hongkui Zeng,et al. Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory , 2001, Cell.
[369] J. Haines,et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. , 2001, JAMA.
[370] C. Dion,et al. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes , 2001, Molecular Psychiatry.
[371] M. Deardorff,et al. A role for frizzled 3 in neural crest development. , 2001, Development.
[372] J. Thome,et al. Potential genetic markers of sporadic Alzheimer's dementia , 2001, Psychiatric genetics.
[373] M. Rugge,et al. Fez1/lzts1 alterations in gastric carcinoma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[374] A. Jablensky,et al. Schizophrenia and cancer: is there a need to invoke a protective gene? , 2001, Archives of general psychiatry.
[375] David Curtis,et al. Genetic association studies of schizophrenia using the 8p21-22 genes: prepronociceptin (PNOC), neuronal nicotinic cholinergic receptor alpha polypeptide 2 (CHRNA2) and arylamine N-acetyltransferase 1 (NAT1) , 2001, European Journal of Human Genetics.
[376] A. Tanskanen,et al. Incidence of cancer among persons with schizophrenia and their relatives. , 2001, Archives of general psychiatry.
[377] G Kalsi,et al. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. , 2001, American journal of human genetics.
[378] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[379] G. Lubec,et al. Aberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brain. , 2001, Journal of neural transmission. Supplementum.
[380] S. Tsai,et al. A study of alpha-adrenoceptor gene polymorphisms and Alzheimer disease , 2001, Journal of Neural Transmission.
[381] J. Knauber,et al. Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the α1b-adrenoceptor , 2000, European Neuropsychopharmacology.
[382] T. Akiyama. Wnt/beta-catenin signaling. , 2000, Cytokine & growth factor reviews.
[383] R. Sulkava,et al. Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over , 2000, Neuroscience Letters.
[384] H. Wiebusch,et al. Roles for lipoprotein lipase in Alzheimer's disease: An association study , 2000, Microscopy research and technique.
[385] Chao-Cheng Lin,et al. No Evidence for Association of Alpha 1a Adrenoceptor Gene Polymorphism and Clozapine-Induced Urinary Incontinence , 2000, Neuropsychobiology.
[386] D. Schaid,et al. Case‐control study of debrisoquine 4‐hydroxylase, n‐acetyltransferase 2, and apolipoprotein e gene polymorphisms in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[387] S. Catts,et al. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? , 2000, Schizophrenia Research.
[388] R. Kerwin,et al. No influence of adrenergic receptor polymorphisms on schizophrenia and antipsychotic response , 2000, Neuroscience Letters.
[389] C. Marsden,et al. Detailed genotyping demonstrates association between the slow acetylator genotype for N‐Acetyltransferase 2 (NAT2) and familial parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[390] M. Hollstein,et al. p53 and human cancer: the first ten thousand mutations. , 2000, Advances in cancer research.
[391] K. Ressler,et al. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders , 2000, Depression and anxiety.
[392] R. Faull,et al. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia , 2000, Molecular Psychiatry.
[393] R. Yolken,et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.
[394] K. Davis,et al. The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease , 1999, Biological Psychiatry.
[395] R. Marconi,et al. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. , 1999, Neurology.
[396] W. Honer,et al. Linkage of familial schizophrenia to chromosome 13q32. , 1999, American journal of human genetics.
[397] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[398] A. Hofman,et al. N-acetyltransferase-2 polymorphism in Parkinson’s disease: the Rotterdam study , 1999, Journal of neurology, neurosurgery, and psychiatry.
[399] J. Dupret,et al. Acetylator genotype for N‐acetyltransferase 2 and Parkinson's disease , 1999, Annals of neurology.
[400] C. Pang,et al. Lipoprotein lipase mutations and Alzheimer's disease. , 1999, American journal of medical genetics.
[401] R. Straub,et al. Marker-to-marker linkage disequilibrium on chromosomes 5q, 6p, and 8p in Irish high-density schizophrenia pedigrees. , 1999, American journal of medical genetics.
[402] D. Bishop,et al. N-acetyltransferase (NAT2) genotype and susceptibility of sporadic Alzheimer's disease. , 1999, Pharmacogenetics.
[403] N. Cairns,et al. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. , 1999, Journal of neural transmission. Supplementum.
[404] F. Jiménez-Jiménez,et al. Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease , 1998, Neurology.
[405] J D Terwilliger,et al. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set , 1998, Molecular Psychiatry.
[406] C. Stefanis,et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21 , 1998, Nature Genetics.
[407] J Blangero,et al. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. , 1998, American journal of medical genetics.
[408] T. Matise,et al. NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. , 1998, American journal of medical genetics.
[409] J. Costentin,et al. Transient expression of the vesicular monoamine transporter during development in the rat thalamus and cortex , 1998, Neuroscience Letters.
[410] M A Geyer,et al. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. , 1998, Schizophrenia bulletin.
[411] P. Worley,et al. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. , 1997, Human molecular genetics.
[412] C. Marsden,et al. Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease , 1997, The Lancet.
[413] R. D. De Abreu,et al. Dihydropyrimidinase deficiency, a progressive neurological disorder? , 1997, Neuropediatrics.
[414] R. Straub,et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. , 1996, The American journal of psychiatry.
[415] P. Goldman-Rakic. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[416] J. Weissenbach,et al. Genetic and physical mapping of the progressive epilepsy with mental retardation (EPMR) locus on chromosome 8p. , 1996, Genome research.
[417] K. Kendler. Seminars in Psychiatric Genetics , 1996 .
[418] W. Dobyns,et al. Absence makes the search grow longer. , 1996, American journal of human genetics.
[419] J. Ott,et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. , 1995, American journal of medical genetics.
[420] J. Weissenbach,et al. The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the distal short arm of chromosome 8. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[421] F. Happé. An advanced test of theory of mind: Understanding of story characters' thoughts and feelings by able autistic, mentally handicapped, and normal children and adults , 1994, Journal of autism and developmental disorders.
[422] A. Ogunniyi,et al. Xenobiotic metabolism in idiopathic Parkinson's disease in Nigerian Africans. , 1993, East African medical journal.
[423] F. Jiménez-Jiménez,et al. Acetylator polymorphism in Alzheimer's disease. , 1993, The European journal of medicine.
[424] M. Cowen,et al. The Kallmann's syndrome variant (KSV) model of the schizophrenias , 1993, Schizophrenia Research.
[425] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[426] B. Leventhal,et al. Autism and tuberous sclerosis , 1991, Journal of autism and developmental disorders.
[427] P. Rothberg,et al. Oncogenes and cancer. , 1983, Cancer investigation.
[428] F. J. Kallmann,et al. Heredity and eugenics. , 1963, The American journal of psychiatry.
[429] Fj Kallmann. The genetic aspects of primary eunuchoidism , 1944 .